IBB - iShares Nasdaq Biote...About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $161.87 | Open | $161.91 |
| Volume | 2.22M | Market Cap | 11.129B |
| Yield | 0.19 % | Last Dividend | $0.31 |
| 5 Biotech Stocks That Generated 1,000%+ ... | 12/26/20 |
| The biopharma sector weathered the COVID-19 pandemic fairly well, with the Shares Nasdaq Biotechnology Etf (NASDAQ: IBB ) outperforming the S&P 500 In... | |
| iShares Nasdaq Biotechnology ETF (NASDAQ... | 11/20/20 |
| ValuEngine cut shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) from a hold rating to a sell rating in a research report report published on Mo... | |
| Biotech ETFs Poised for Gains after Mode... | 11/16/20 |
| Biotech ETFs are getting a boost along with stocks on Monday thanks to Moderna, which announced that its initial phase three trial data reveals a coro... | |
| Bluebird bio's stock plunges after submi... | 11/05/20 |
| Shares of Bluebird bio Inc. traded 15.1% into the red in morning trading Thursday, after the gene therapy company pushed back the U.S. submission for ... | |
| The Week Ahead In Biotech: Kala FDA Deci... | 10/25/20 |
| Biotech stocks posted weekly declines in the week ended Oct. 23, pressured by the broader market decline amid mixed earnings reports and the impasse o... | |
| Aptinyx stock soars on premarket leading... | 10/20/20 |
| Shares of Aptinyx Inc. shot up 61% on heavy volume in premarket trading Tuesday, putting them on track to open at a 20-month high, after the biopharma... | |
| Big Biotech Stands Tall Amid Race for Vi... | 07/17/20 |
| The iShares Nasdaq Biotechnology ETF (IBB) is among the biotechnology ETFs that are shining this year as companies scramble to develop treatments and ... | |
| Big Biotech Stands Tall Amid Race for Vi... | 07/17/20 |
| The iShares Nasdaq Biotechnology ETF (IBB) is among the biotechnology ETFs that are shining this year as companies scramble to develop treatments and ... | |
| 3 Gilead-Heavy ETFs To Watch Amid The As... | 06/08/20 |
| In the race to develop a coronavirus vaccine, AstraZeneca (NYSE: AZN ) and Gilead Sciences (NASDAQ: GILD ) are two of the leading contenders and that ... | |
| Dow spikes 912 points as vaccine progres... | 05/18/20 |
| US stocks surged on Monday as Moderna announced that its coronavirus vaccine candidate had shown encouraging progress. In a small number of healthy vo... | |
| The Week Ahead In Biotech: Virtual Confe... | 05/10/20 |
| The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotec... | |
| Spherix stock soars after option execute... | 03/06/20 |
| Shares of Spherix Inc. soared 21% in active morning trading Friday, after the biotechnology company said it executed an exclusive option agreement wit... | |
| The Week Ahead In Biotech: JPMorgan Heal... | 01/12/20 |
| Activity in the biotech space is likely to pick up this week. Events are likely to be headlined by the annual JPMorgan Healthcare Conference. Biotech ... | |
| Week Ahead In Biotech: PDUFA Date Ahead ... | 12/29/19 |
| Biotech stocks advanced in the penultimate week of the year, and the iShares NASDAQ Biotechnology Index (NASDAQ: IBB ) is on track to end the year wit... | |
| Biotech Sector ETFs Are Looking Up | 12/23/19 |
| Biotechnology stocks and sector-related ETFs are finally beginning to shine, and their current momentum could be maintained into the new year. The iSh... | |
| The Week Ahead In Biotech: Correvio, Int... | 12/22/19 |
| Biotech stocks have been buoyant in recent sessions, as reflected by the iShares NASDAQ Biotechnology Index (NASDAQ: IBB ), which traded higher for th... | |
| Medical breakthroughs, looser FDA made b... | 12/22/19 |
| By the numbers, a $1,000 stake in the iShares Nasdaq Biotechnology ETF in December 2009 would now be worth over $4,500. | |
| Biotech ETFs Slip as Trump Administratio... | 12/18/19 |
| Biotechnology sector ETFs weakened Wednesday as the Trump administration pushes forward plans to allow the importation of cheaper drugs in an attempt ... | |
| The Week Ahead In Biotech: Avadel, Epizy... | 12/15/19 |
| Biotech stocks were seen consolidating last week after advancing in the previous week. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB ) reached a... | |
| Investors Are Moving Back Into Resurgent... | 12/09/19 |
| After stumbling through much of 2019, biotechnology ETFs are finding their grooves in the fourth quarter. Since the start of the current quarter, the ... | |
| Chart of the Day: iShares Nasdaq Biotech... | 12/06/19 |
| The biotech sector has gained more than 20% in the 4th quarter of 2019 but it looks like the rally has run out of steam. | |
| Attention Biotech Investors: Mark Your C... | 11/29/19 |
| Biotech stocks had a fairly robust November, with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB ) advancing over 10% for the month. This compare... | |
| iShares NASDAQ Biotechnology Index Fund ... | 09/05/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 4) ... | |
| iShares NASDAQ Biotechnology Index Fund ... | 09/04/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 3) ... | |
| Biotech Stock On The Radar: Is Vanda A B... | 08/13/19 |
| Small-cap biopharma Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ) has withstood the market-wide sell-off witnessed in early August, thanks to the second-... | |
| Biotech Stock On The Radar: Evoke Pharma... | 07/25/19 |
| Evoke Pharma, Inc. (NASDAQ: EVOK ) shares have lost about 51% of their value year to date compared to the 9.4%-gain in the iShares NASDAQ Biotechnolog... | |
| Why Bristol-Myers Squibb Stock Is Stumbl... | 07/23/19 |
| Ahead of its quarterly earnings report scheduled for July 25, Bristol-Myers Squibb (NYSE:BMY) found itself trading at fresh 52-week lows. While BMY st... | |
| 3 Gene Therapy Stocks For A Biotech Port... | 05/20/19 |
| No summary available. | |
| Outlook Therapeutics' stock rockets on h... | 05/17/19 |
| Shares of Outlook Therapeutics Inc. rocketed 38% in very active morning trade Friday, putting them on track to more than double in two days. Volume ba... | |
| IBB, GILD, CELG, BIIB: ETF Outflow Alert | 05/15/19 |
| Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Nasdaq Biotec... | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Spread Hacker | MrToptick | 86.00 % | Follow |
| Options Eagle | George | 78.00 % | Follow |
| Exegesis | jonathan taylor | 70.00 % | Subscribe |
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
| High % winning options and leveraged ETFs | Scott T | 68.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
